Skip to content
buyModerate

Clay B Siegall bought $250k of STTK

director at Shattuck Labs, Inc.. 62,500 shares at an average of $4.00, traded Jun 9, 2026, filed Jun 11, 2026.

Conviction score
42
Value
$250k
62,500 shares
Holdings after
318,608
+24% from before
From 52-week low
+483%
low $0.73, close $4.27
From 52-week high
-46%
high $7.88, as of Jun 9, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $250k at market
    +13
  • Relative to holdings
    Holdings up 24%
    +6
  • Price context
    46% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

STTKOct 12, 2026 · close 6.09
Since filing Jun 11, 2026: +45.7%SPY +6.0% · excess +39.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-267836, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 9, 2026POpen-market purchase
Common Stock
+62,500$4.00$250k318,608Jun 11, 2026

Related signals

Other insiders at Shattuck Labs, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
0Weak
STTKsell 210b5-1
Shattuck Labs, Inc.
Abhinav A. Shukla
Chief Technical Officer
$2,874
410 shares
-0%
20Weak
STTKsell 210b5-1
Shattuck Labs, Inc.
Arundathy N. Pandite
Chief Medical Officer
$210k
30,000 shares
-18%
4Weak
STTKsell 210b5-1
Shattuck Labs, Inc.
Abhinav A. Shukla
Chief Technical Officer
$166k
23,465 shares
-21%
20Weak
STTKsell 210b5-1
Shattuck Labs, Inc.
Arundathy N. Pandite
Chief Medical Officer
$198k
30,000 shares
-15%
0Weak
STTKsell 210b5-1
Shattuck Labs, Inc.
Abhinav A. Shukla
Chief Technical Officer
$14k
2,032 shares
-2%
64Notable
STTKbuy 2
Shattuck Labs, Inc.
Mona Ashiya
director
$5.5M
6,306,127 shares
-
64Notable
STTKbuy 2
Shattuck Labs, Inc.
Orbimed Advisors LLC
director
$5.5M
6,306,127 shares
-
26Weak
STTKbuy
Shattuck Labs, Inc.
Redmile Group, LLC
director, owner
$167k
133,371 shares
+2%
26Weak
STTKsell
Shattuck Labs, Inc.
Redmile Group, LLC
director, owner
$167k
133,371 shares
-2%
0Weak
STTKsell10b5-1
Shattuck Labs, Inc.
Stephen Stout
See Remarks
$169k
16,004 shares
-19%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Clay B Siegall bought $250k of STTK | InsiderTell